Maor Yaakov, Nadler Moshe, Barshack Iris, Zmora Oded, Koller Moshe, Kundel Yulia, Fidder Herma, Bar-Meir Simon, Avidan Benjamin
Department of Gastroenterology, Sheba Medical Center, Tel-Hashomer, Israel.
J Gastroenterol Hepatol. 2006 Feb;21(2):454-8. doi: 10.1111/j.1440-1746.2005.03927.x.
Endoscopic ultrasound (EUS) has been shown to be a reliable tool for staging rectal cancer. Nevertheless, the accuracy of EUS after chemoradiation remains unclear; therefore the purpose of the present paper was to compare the accuracy of EUS staging for rectal cancer before and following chemoradiation.
Patients with rectal cancer undergoing EUS staging were stratified into two groups. Group I consisted of 66 patients who underwent surgery following EUS staging without preoperative chemoradiation. Group II consisted of 25 patients who had EUS evaluation following chemoradiation. The EUS staging was compared to surgical/pathological staging.
The accuracy of the T staging for group I was 86% (57/66). Inaccurate staging was mainly associated with overstaging EUS T2 tumors. The accuracy of the N staging for group I was 71% (47/66). The accuracy of EUS for a composite T and N staging relevant to treatment decisions in group I was 91%. In group II, the accuracy of T and N staging was 72% (18/25) and 80% (20/25), respectively. Overstaging EUS T3 tumors accounted for most inaccurate staging. The EUS staging predicted post-chemoradiation T0N0 stage correctly in only 50% of cases.
Preoperative staging of rectal cancer by EUS is a useful modality in determining the need for preoperative chemoradiation. The EUS T staging following chemoradiation appears to be less accurate. Detection of complete response may be insufficient for selecting patients for limited surgical intervention.
内镜超声(EUS)已被证明是直肠癌分期的可靠工具。然而,放化疗后EUS的准确性仍不明确;因此,本文的目的是比较放化疗前后EUS对直肠癌分期的准确性。
接受EUS分期的直肠癌患者被分为两组。第一组由66例在未进行术前放化疗的EUS分期后接受手术的患者组成。第二组由25例在放化疗后接受EUS评估的患者组成。将EUS分期与手术/病理分期进行比较。
第一组T分期的准确性为86%(57/66)。分期不准确主要与EUS对T2期肿瘤的过度分期有关。第一组N分期的准确性为71%(47/66)。第一组中与治疗决策相关的T和N综合分期的EUS准确性为91%。在第二组中,T分期和N分期的准确性分别为72%(18/25)和80%(20/25)。EUS对T3期肿瘤的过度分期占大多数分期不准确的情况。EUS分期仅在50%的病例中正确预测了放化疗后的T0N0期。
EUS对直肠癌进行术前分期是确定是否需要术前放化疗的有用方法。放化疗后的EUS T分期似乎不太准确。检测完全缓解可能不足以选择患者进行有限的手术干预。